Health
First-Ever Treatment for "Childhood Alzheimer's" Approved as FDA Clears Ultragenyx Gene Therapy
Families facing Sanfilippo syndrome type A now have "hope and an action plan," advocates say.
All Happy News Company coverage of Ultragenyx: the latest health news, with links to every original source.
Families facing Sanfilippo syndrome type A now have "hope and an action plan," advocates say.
Publish your impact story, donation, milestone or community launch on Happy News Company from $99. Nonprofits save 25%.